Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(375)
Robert J. Myerson
20
James W. Fleshman
15
Elisa H. Birnbaum
15
Ira J. Kodner
14
Benjamin R. Tan
12
Journals
(32)
INT J RADIAT ONCOL BIOL PHYS
11
J CLIN ONCOL
8
Cancer
5
J UROL
5
CANCER CHEMOTHER PHARMACOL
4
Keywords
(182)
Embed
Subscribe
Academic
Authors
Joel Picus
Joel Picus,Washington University in St. Louis,Oncology,Pharmacology,Urology
Edit
Joel Picus
Washington University in St. Louis
Publications:
75
|
Citations:
1233
Fields:
Oncology
,
Pharmacology
,
Urology
View FAQ about top research areas and Fields of study
Collaborated with
375 co-authors
from 1985 to 2011
|
Cited by
4907 authors
Cumulative
Annual
Sort by:
Publications
(75)
BibTeX
|
RIS
|
RefWorks
Download
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
(
Citations: 1
)
Paula M. Fracasso
,
Kerry J. Williams
,
Ronald C. Chen
,
Joel Picus
,
Cynthia X. Ma
,
Matthew J. Ellis
,
Benjamin R. Tan
,
Timothy J. Pluard
,
Douglas R. Adkins
,
Michael J. Naughton
,
Janet S. Rader
,
Matthew A. Arquette
http://academic.research.microsoft.com/io.ashx?type=5&id=32518811&selfId1=23140453&selfId2=0&maxNumber=12&query=
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 67, no. 6, pp. 1225-1237, 2011
6597 POSTER A Phase II Study of Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma – a Multicenter Study of the Mayo Phase 2 Consortium (P2C) and the Cancer Therapeutics Research Group (CTRG)
W. Yeo
,
H. C. Chung
,
S. L. Chan
,
L. Z. Wang
,
R. Lim
,
J. Picus
,
M. Boyer
,
C. Erlichman
,
A. T. C. Chan
,
B. C. Goh
Journal:
European Journal of Cancer - EUR J CANCER
, vol. 47, pp. S470-S471, 2011
A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α v integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer
Franklin M. Chu
,
Joel Picus
,
Paula M. Fracasso
,
Robert Dreicer
,
Zhihui Lang
,
Brenda Foster
Journal:
Investigational New Drugs - INVEST NEW DRUG
, vol. 29, no. 4, pp. 674-679, 2011
Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
Matthew H Kulke
,
Johanna Bendell
,
Larry Kvols
,
Joel Picus
,
Rodney Pommier
,
James Yao
Journal:
Journal of Hematology & Oncology - J HEMATOL ONCOL
, vol. 4, no. 1, pp. 1-8, 2011
Phase I Study of Single-Agent Anti-Programmed Death1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
(
Citations: 42
)
J. R. Brahmer
,
C. G. Drake
,
I. Wollner
,
J. D. Powderly
,
J. Picus
,
W. H. Sharfman
,
E. Stankevich
,
A. Pons
,
T. M. Salay
,
T. L. McMiller
,
M. M. Gilson
,
C. Wang
http://academic.research.microsoft.com/io.ashx?type=5&id=30847566&selfId1=23140453&selfId2=0&maxNumber=12&query=
Journal:
Journal of Clinical Oncology - J CLIN ONCOL
, vol. 28, no. 19, pp. 3167-3175, 2010
Sort by:
Citations
(1233 times by 1138 publications)
Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device
Brian J. Kirby
,
Mona Jodari
,
Matthew S. Loftus
,
Gunjan Gakhar
,
Erica D. Pratt
,
Chantal Chanel-Vos
,
Jason P. Gleghorn
,
Steven M. Santana
,
He Liu
,
James P. Smith
,
Vicente N. Navarro
,
Scott T. Tagawa
http://academic.research.microsoft.com/io.ashx?type=5&id=57404109&selfId1=23140453&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 4, 2012
Extended CoExpression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
Lukas Baitsch
,
Amandine Legat
,
Leticia Barba
,
Silvia A. Fuertes Marraco
,
Jean-Paul Rivals
,
Petra Baumgaertner
,
Céline Christiansen-Jucht
,
Hanifa Bouzourene
,
Donata Rimoldi
,
Hanspeter Pircher
,
Nathalie Rufer
,
Maurice Matter
http://academic.research.microsoft.com/io.ashx?type=5&id=57402490&selfId1=23140453&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 2, 2012
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines
R Grepin
,
M Guyot
,
M Jacquin
,
J Durivault
,
E Chamorey
,
A Sudaka
,
C Serdjebi
,
B Lacarelle
,
J-Y Scoazec
,
S Negrier
,
H Simonnet
,
G Pages
Journal:
Oncogene
, vol. 31, no. 13, pp. 1683-1694, 2012
Cell Cycle Gene Networks Are Associated with Melanoma Prognosis
Li Wang
,
Daniel G. Hurley
,
Wendy Watkins
,
Hiromitsu Araki
,
Yoshinori Tamada
,
Anita Muthukaruppan
,
Louis Ranjard
,
Eliane Derkac
,
Seiya Imoto
,
Satoru Miyano
,
Edmund J. Crampin
,
Cristin G. Print
Journal:
PLOS One
, vol. 7, no. 4, 2012
Unmasking the immune recognition of prostate cancer with CTLA4 blockade
Serena S. Kwek
,
Edward Cha
,
Lawrence Fong
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 12, no. 4, pp. 289-297, 2012
Comments